Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 230(Granted Patents)

Location History:

Toulouse, FR (1978 - 1998)
alle de Barcelone, FR (1998)
Estadens, FR (2007 - 2011)

Company Filing History:

Years Active: 1978-2011

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7879889 - Therapeutic use of acylaminothiazole derivatives (2011-02-01),

2. 7563903 - Acylaminothiazole derivatives, their preparation and their therapeutic use (2009-07-21),

3. 7288659 - Acylaminothiazole derivatives, their preparation and therapeutic use (2007-10-30),

4. 5798353 - Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one (1998-08-25),

5. 5731340 - Glycinamide derivatives, processes for their preparation and medicines (1998-03-24),

6. 5719143 - Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one (1998-02-17),

7. 5656648 - Polysubstituted 2-amino-thiazole derivatives (1997-08-12),

8. 5576328 - Method for the secondary prevention of ischemic events (1996-11-19),

9. 5534530 - 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical (1996-07-09),

10. 5252749 - Ethers of thienocyclopentanone oximes, their preparation and (1993-10-12),

11. 5190938 - Derivatives of 2-hydroxythiophene and -furan fused with a (1993-03-02),

12. 5189049 - Heterocyclic substituted acylaminothiazoles, their preparation and (1993-02-23),

13. 4977168 - Derivatives of the N (1990-12-11),

14. 4847265 - Dextro-rotatory enantiomer of methyl alpha-5 (4,5,6,7-tetrahydro (3,2-c) (1989-07-11),

15. 4791102 - Derivatives of the N (1988-12-13),

Title: **Daniel Frehel: Innovator in Therapeutic Patents**

Introduction

Daniel Frehel is a prominent inventor located in Toulouse, France, known for his contributions to the field of therapeutics with a total of 22 patents to his name. His innovative work focuses on developing acylaminothiazole derivatives, which hold significant promise for therapeutic applications.

Latest Patents

Among his latest patents, Frehel has disclosed and claimed various therapeutic uses of compounds corresponding to a specific general formula. These compounds utilize acylaminothiazole derivatives, which have been described with precision in terms of their components and potential health benefits. Frehel's application details the compounds' structure, including variations where R represents different chemical groups, showcasing his deep understanding of medicinal chemistry.

Career Highlights

Frehel has built a notable career through his work with reputable companies such as Sanofi and Elf Sanofi. His innovative contributions within these organizations have significantly advanced the development of therapeutic drugs, directly impacting patient care and treatment options.

Collaborations

Throughout his career, Frehel has collaborated with various talented individuals in his field. Notable coworkers include Jean-Pierre Maffrand and Alain Badorc, who have contributed to the successful development and patenting of therapeutic innovations alongside Frehel.

Conclusion

In summary, Daniel Frehel has established himself as a key figure in the landscape of pharmaceutical innovation through his 22 patents and impactful collaborations. His latest developments in acylaminothiazole derivatives highlight the potential for new therapeutic applications, reflecting his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.